To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 7, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
End Stage Renal Disease (ESRD)
Interventions
BIOLOGICAL

Acellular Tissue Engineered Vessel (ATEV)

ATEV implantation

OTHER

AVF

AVF creation procedure

Trial Locations (32)

10595

RECRUITING

Ambulatory Care Pavilion Westchester Medical Center, Valhalla

11355

RECRUITING

New York-Presbyterian Queens_The Lang Center for Research & Education, Flushing

19140

RECRUITING

Temple University, Philadelphia

21287

RECRUITING

John Hopkins University School of Medicine, Baltimore

27157

RECRUITING

Wake Forest University School of Medicine_Atrium Health Wake Forest Baptist, Winston-Salem

27704

RECRUITING

Duke Regional Hospital, Durham

28207

RECRUITING

Surgical Specialists of Charlotte, Charlotte

30046

RECRUITING

Georgia Nephrology, Atlanta

30303

RECRUITING

Grady Memorial Hospital, Atlanta

32224

RECRUITING

Mayo Clinic Florida, Jacksonville

32608

RECRUITING

University of FL Health Heart and Vascular Hospital, Gainesville

33156

RECRUITING

American Access Care of Miami, LLC, Miami

33606

RECRUITING

USF Health South Tampa, Tampa

34613

RECRUITING

Access Research Institute, Brooksville

37920

RECRUITING

University of Tennessee Medical Center, Knoxville

47408

RECRUITING

IU Health Bloomington Hospital, Bloomington

48109

RECRUITING

University of Michigan, Ann Arbor

78221

RECRUITING

San Antonio Vascular and Endovascular Clinic PLLC, San Antonio

RECRUITING

The San Antonio Vascular and Endovascular Clinic, San Antonio

78701

RECRUITING

Dell Seton Medical Center at The University of Texas at Austin, Austin

79407

RECRUITING

Dr. Ruben Villa__Nephrology, Lubbock

79410

RECRUITING

Cataract & Surgery Center Lubbock, Lubbock

80204

RECRUITING

Denver Health and Hospital Authority, Denver

85260

RECRUITING

Honor Health Scottsdale Shea Medical Center, Scottsdale

92037

RECRUITING

Jacob's Medical Center at UC San Diego Health, La Jolla

92243

RECRUITING

El Centro Regional Medical Center, El Centro

06519

RECRUITING

Yale New Haven Hospital, New Haven

02115

RECRUITING

Brigham and Women's Hospital, Boston

02118

RECRUITING

Boston Medical Center, Boston

07103

RECRUITING

Rutgers University_Medical, Newark

07503

RECRUITING

St.Joseph's University Medical Center, Paterson

08534

RECRUITING

Capital Health Medical Center- Hopewell, Pennington

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

IQVIA Biotech

INDUSTRY

lead

Humacyte, Inc.

INDUSTRY

NCT05908084 - To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis | Biotech Hunter | Biotech Hunter